A prospective, randomized, multicenter, and long-range study could provide more definitive evidence to compare the effects of PPA and SGA on the expression of serum VEGF and TGF-β in patients undergoing radical resection of lung cancer. The gene discussed is TGFB1; the disease is lung carcinoma.